Skip to main content

Erratum to: Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

The Original Article was published on 27 January 2016

The original version of this article (Hastedt et al. 2016) contained an error. The twelfth author’s name was inadvertently misspelled. The correct spelling is Masahiro Sakagami.

Reference

  • Hastedt JE, Per B, Clark AR, William D, Anthony H, Guenther H, Kuehl PJ, Claus-Michael L, Peter M, Jason MC, Ralph N, Masahiro S, Weers JG (2016) Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD. AAPS Open 2:1

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jayne E. Hastedt.

Additional information

The online version of the original article can be found under doi:10.1186/s41120-015-0002-x.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hastedt, J.E., Bäckman, P., Clark, A.R. et al. Erratum to: Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD. AAPS Open 2, 4 (2016). https://doi.org/10.1186/s41120-016-0005-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s41120-016-0005-2